A national survey of the availability of intensity-modulated radiation therapy and stereotactic radiosurgery in Canada

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  AlDuhaiby, Eman Z ^a   Breen, Stephen ^a,b   Bissonnette, Jean Pierre ^a,b   Sharpe, Michael ^a,b   Mayhew, Linda ^b   Tyldesley, Scott ^c   Wilke, Derek R ^d   Hodgson, David C ^a,b,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Intensity modulated radiation therapy; Stereotactic radiosurgery; Survey

Indexed keywords

ARTICLE; CANADA; COMPUTER PROGRAM; CONTROLLED STUDY; EQUIPMENT; HEAD AND NECK CANCER; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH SURVEY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; ONCOLOGY; PATIENT REFERRAL; RAILWAY; STEREOTACTIC RADIOSURGERY; TREATMENT PLANNING; INFORMATION PROCESSING; RADIOSURGERY; UTILIZATION REVIEW;

CANADA; DATA COLLECTION; HUMANS; RADIOSURGERY; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84860431614     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-18     Document Type: Article

References (35)

1. Nutting C. Intensity modulated radiation therapy: a clinical review. Br J Radiol 2000, 73:459-469.
2. Lu TX, Mai WY, Teh BS, Zhao C, Han F, Huang Y, Deng XW, Lu LX, Huang SM, Zeng ZF, et al. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2004, 58:682-687. 10.1016/S0360-3016(03)01508-6, 14967420.
3. Zelefsky MJ, Fuks Z, Hunt M, Lee HJ, Lombardi D, Ling CC, Reuter VE, Venkatraman ES, Leibel SA. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 2001, 166:876-881. 10.1016/S0022-5347(05)65855-7, 11490237.
4. Barnett GC, Wilkinson J, Moody AM, Wilson CB, Sharma R, Klager S, Hoole AC, Twyman N, Burnet NG, Coles CE. A randomised controlled trial of forward-planned radiotherapy (IMRT) for early breast cancer: baseline characteristics and dosimetry results. Radiother Oncol 2009, 92:34-41. 10.1016/j.radonc.2009.03.003, 19375808.
5. Donovan E, Bleakley N, Denholm E, Evans P, Gothard L, Hanson J, Peckitt C, Reise S, Ross G, Sharp G, et al. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 2007, 82:254-264. 10.1016/j.radonc.2006.12.008, 17224195.
6. Kam MK, Leung SF, Zee B, Chau RM, Suen JJ, Mo F, Lai M, Ho R, Cheung KY, Yu BK, et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 2007, 25:4873-4879. 10.1200/JCO.2007.11.5501, 17971582.
7. Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, Miles EA, Miah AB, Newbold K, Tanay M, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011, 12:127-136. 10.1016/S1470-2045(10)70290-4, 3033533, 21236730.
8. Pignol JP, Olivotto I, Rakovitch E, Gardner S, Sixel K, Beckham W, Vu TT, Truong P, Ackerman I, Paszat L. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 2008, 26:2085-2092. 10.1200/JCO.2007.15.2488, 18285602.
9. Pow EH, Kwong DL, McMillan AS, Wong MC, Sham JS, Leung LH, Leung WK. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 2006, 66:981-991. 10.1016/j.ijrobp.2006.06.013, 17145528.
10. Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A, Amols HI. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70:1124-1129. 10.1016/j.ijrobp.2007.11.044, 18313526.
11. Veldeman L, Madani I, Hulstaert F, De Meerleer G, Mareel M, De Neve W. Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies. Lancet Oncol 2008, 9:367-375. 10.1016/S1470-2045(08)70098-6, 18374290.
12. Staffurth J. A Review of the Clinical Evidence for Intensity-modulated Radiotherapy. Clin Oncol (R Coll Radiol) 2010, 22:643-657.
13. Nutting C. First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PASSPORT: ISRCTN48243537; CRUK/03/005) [abstract]. J Clin Oncol 2009, 27:s18.
14. Viani GA, Stefano EJ, Afonso SL. Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials. Int J Radiat Oncol Biol Phys 2009, 74:1405-1418. 10.1016/j.ijrobp.2008.10.091, 19616743.
15. Sahgal A, Ma L, Chang E, Shiu A, Larson DA, Laperriere N, Yin FF, Tsao M, Menard C, Basran PS, et al. Advances in technology for intracranial stereotactic radiosurgery. Technol Cancer Res Treat 2009, 8:271-280.
16. Linskey ME, Andrews DW, Asher AL, Burri SH, Kondziolka D, Robinson PD, Ammirati M, Cobbs CS, Gaspar LE, Loeffler JS, et al. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2009, 96:45-68. 2808519, 19960227.
17. Mehta MP, Tsao MN, Whelan TJ, Morris DE, Hayman JA, Flickinger JC, Mills M, Rogers CL, Souhami L, Mehta MP, et al. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2005, 63:37-46. 10.1016/j.ijrobp.2005.05.023, 16111570.
18. Tsao MN, Lloyd NS, Wong RK, . Supportive Care Guidelines Group of Cancer Care Ontario's Program in Evidence-based Care Clinical practice guideline on the optimal radiotherapeutic management of brain metastases. BMC Cancer 2005, 5:34. 10.1186/1471-2407-5-34, 1090562, 15807895, Supportive Care Guidelines Group of Cancer Care Ontario's Program in Evidence-based Care.
19. Jefferies S, Taylor A, Reznek R. Results of a National Survey of Radiotherapy Planning and Delivery in the UK in 2007. Clin Oncol (R Coll Radiol) 2009, 21:204-217.
20. Mayles WPM. Survey of the Availability and Use of Advanced Radiotherapy Technology in the UK. Clin Oncol (R Coll Radiol) 2010, 22:636-642.
21. Mell LK, Mehrotra AK, Mundt AJ. Intensity-modulated radiation therapy use in the U.S., 2004. Cancer 2005, 104:1296-1303. 10.1002/cncr.21284, 16078260.
22. Mell LK, Roeske JC, Mundt AJ. A survey of intensity-modulated radiation therapy use in the United States. Cancer 2003, 98:204-211. 10.1002/cncr.11489, 12833473.
23. Muren LP, Mella O, Hafslund R, Dahl O. Norwegian oncologists' expectations of intensity-modulated radiotherapy. Acta Oncol 2002, 41:562-565. 10.1080/02841860214967, 12546530.
24. Teshima T, Numasaki H, Shibuya H, Nishio M, Ikeda H, Sekiguchi K, Kamikonya N, Koizumi M, Tago M, Ando Y, et al. Japanese structure survey of radiation oncology in 2007 based on institutional stratification of patterns of care study. Int J Radiat Oncol Biol Phys 2010, 78:1483-1493. 10.1016/j.ijrobp.2009.10.019, 20378263.
25. Williams MV, Cooper T, Mackay R, Staffurth J, Routsis D, Burnet N. The implementation of intensity-modulated radiotherapy in the UK. Clin Oncol (R Coll Radiol) 2010, 22:623-628.
26. Das IJ, Moskvin V, Johnstone PA, Das IJ, Moskvin V, Johnstone PA. Analysis of treatment planning time among systems and planners for intensity-modulated radiation therapy. J Amer Coll Radiol 2009, 6:514-517.
27. Williamson JF, Dunscombe PB, Sharpe MB, Thomadsen BR, Purdy JA, Deye JA. Quality assurance needs for modern image-based radiotherapy: recommendations from 2007 interorganizational symposium on "quality assurance of radiation therapy: challenges of advanced technology". Int J Radiat Oncol Biol Phys 2008, 71:S2-12. 10.1016/j.ijrobp.2007.08.080, 18406928.
28. Hartford AC, Palisca MG, Eichler TJ, Beyer DC, Devineni VR, Ibbott GS, Kavanagh B, Kent JS, Rosenthal SA, Schultz CJ, et al. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guidelines for Intensity-Modulated Radiation Therapy (IMRT). Int J Radiat Oncol Biol Phys 2009, 73:9-14. 10.1016/j.ijrobp.2008.04.049, 19100920.
29. Alber M, Broggi S, De Wagter C, Eichwurzel I, Engström P, Fiorino C, Georg D, Hartmann G, Knöös T, Leal A, et al. Guidelines for the verfication of IMRT. , http://www.estro-education.org/publications/Documents/Booklet_n9_P3.pdf
30. Whitton A, Warde P, Sharpe M, Oliver TK, Bak K, Leszczynski K, Etheridge S, Fleming K, Gutierrez E, Favell L. Organisational Standards for the Delivery of Intensity-modulated Radiation Therapy in Ontario. Clin Oncol (R Coll Radiol) 2009, 21:192-203.
31. Bak K, Dobrow MJ, Hodgson D, Whitton A. Factors affecting the implementation of complex and evolving technologies: multiple case study of intensity-modulated radiation therapy (IMRT) in Ontario, Canada. BMC Health Serv Res 2011, 11:178. 10.1186/1472-6963-11-178, 3164623, 21801450.
32. Radiation Therapy Evidence-based Series. , https://www.cancercare.on.ca/toolbox/qualityguidelines/clin-program/radther/
33. O'Sullivan B, Rumble RB, Warde P. The Role of IMRT in Head and Neck Cancer. , https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=86987
34. Bauman G, Rumble RB, Chen J, Loblaw A, Warde P. The Role of IMRT in Prostate Cancer. , https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=86979
35. Dayes I, Rumble RB, Bowen J, Dixon P, Warde P. The Role of IMRT in Breast Cancer. , https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=86983